Striatal Presynaptic Dopamine in Schizophrenia, Part II: Meta-Analysis of [18F/11C]-DOPA PET Studies

被引:165
|
作者
Fusar-Poli, Paolo [1 ]
Meyer-Lindenberg, Andreas [2 ]
机构
[1] Univ Pavia, Dept Hlth Sci, Sect Psychiat, I-27100 Pavia, Italy
[2] Heidelberg Univ, Med Fac Mannheim, Cent Inst Mental Hlth, D-6800 Mannheim, Germany
关键词
neuroimaging; PET; striatum; dopamine; schizophrenia; psychosis; antipsychotic; POSITRON-EMISSION-TOMOGRAPHY; SYNTHESIS CAPACITY; PREFRONTAL CORTEX; PRODROMAL SIGNS; BRAIN; PSYCHOSIS; RELEASE; NAIVE; DYSFUNCTION; PREDICTION;
D O I
10.1093/schbul/sbr180
中图分类号
R749 [精神病学];
学科分类号
100205 ;
摘要
Background: Alterations in striatal dopamine neurotransmission are central to the emergence of psychotic symptoms and to the mechanism of action of antipsychotics. Although the functional integrity of the presynaptic system can be assessed by measuring striatal dopamine synthesis capacity (DSC), no quantitative meta-analysis is available. Methods: Eleven striatal (caudate and putamen) [C-11/F-18]-DOPA positron emission tomography studies comparing 113 patients with schizophrenia and 131 healthy controls were included in a quantitative meta-analysis of DSC. Demographic, clinical, and methodological variables were extracted from each study or obtained from the authors and tested as covariates. Hedges' g was used as a measure of effect size in Comprehensive Meta-Analysis. Publication bias was assessed with funnel plots and Egger's intercept. Heterogeneity was addressed with the Q statistic and I-2 index. Results: Patients and controls were well matched in sociodemographic variables (P > .05). Quantitative evaluation of publication bias was nonsignificant (P = .276). Heterogeneity across study was modest in magnitude and statistically nonsignificant (Q = 19.19; P = .078; I-2 = 39.17). Patients with schizophrenia showed increased striatal DSC as compared with controls (Hedges' g = 0.867, CI 95% from 0.594 to 1.140, Z = 6.222, P < .001). The DSC schizophrenia/control ratio showed a relatively homogenous elevation of around 14% in schizophrenic patients as compared with controls. DSC elevation was regionally confirmed in both caudate and putamen. Controlling for potential confounders such as age, illness duration, gender, psychotic symptoms, and exposure to antipsychotics had no impact on the results. Sensitivity analysis confirmed robustness of meta-analytic findings. Conclusions: The present meta-analysis showed consistently increased striatal DSC in schizophrenia, with a 14% elevation in patients as compared with healthy controls.
引用
收藏
页码:33 / 42
页数:10
相关论文
共 50 条
  • [41] Striatal dopaminergic function in restless legs syndrome -: 18F-dopa and 11C-raclopride PET studies
    Turjanski, N
    Lee, AJ
    Brooks, DJ
    NEUROLOGY, 1999, 52 (05) : 932 - 937
  • [42] PET studies in presymptomatic and symptomatic Huntington's disease patients comparison [18F]fluorodeoxyglucose, [11C]raclopride and [11C]SCH-23390
    Stewart, DJ
    Hussey, D
    Jones, C
    Houle, S
    Thomson, J
    Guttman, M
    NEUROLOGY, 1998, 50 (04) : A348 - A348
  • [43] Measuring Amphetamine-Induced Dopamine Release in Humans: A Comparative Meta-Analysis of [11C]-Raclopride and [11C]-(+)-PHNO Studies
    Caravaggio, Fernando
    Porco, Natasha
    Kim, Julia
    Carmona, Edgardo Torres
    Brown, Eric
    Iwata, Yusuke
    Nakajima, Shinichiro
    Gerretsen, Philip
    Remington, Gary
    Graff-Guerrero, Ariel
    BIOLOGICAL PSYCHIATRY, 2021, 89 (09) : S94 - S95
  • [44] Measuring amphetamine-induced dopamine release in humans: A comparative meta-analysis of [11C]-raclopride and [11C]-(+)-PHNO studies
    Caravaggio, Fernando
    Porco, Natasha
    Kim, Julia
    Torres-Carmona, Edgardo
    Brown, Eric
    Iwata, Yusuke
    Nakajima, Shinichiro
    Gerretsen, Philip
    Remington, Gary
    Graff-Guerrero, Ariel
    SYNAPSE, 2021, 75 (05)
  • [45] Comparison of [18F]FIMP, [11C]MET, and [18F]FDG PET for early-phase assessment of radiotherapy response
    Nozaki, Satoshi
    Nakatani, Yuka
    Mawatari, Aya
    Shibata, Nina
    Hume, William E.
    Hayashinaka, Emi
    Wada, Yasuhiro
    Doi, Hisashi
    Watanabe, Yasuyoshi
    SCIENTIFIC REPORTS, 2023, 13 (01)
  • [46] Comparison of [18F]FIMP, [11C]MET, and [18F]FDG PET for early-phase assessment of radiotherapy response
    Satoshi Nozaki
    Yuka Nakatani
    Aya Mawatari
    Nina Shibata
    William E. Hume
    Emi Hayashinaka
    Yasuhiro Wada
    Hisashi Doi
    Yasuyoshi Watanabe
    Scientific Reports, 13
  • [47] Comparing [18F]FET PET and [18F]FDOPA PET for glioma recurrence diagnosis: a systematic review and meta-analysis
    Yu, Pengbo
    Wang, Yinan
    Su, Fengbo
    Chen, Yan
    FRONTIERS IN ONCOLOGY, 2024, 13
  • [48] Effects of sensory stimulation on striatal dopamine release in normal subjects:: A PET 18F-dopa and 11C-Raclopride study
    Thobois, SC
    Leviel, V
    Garcia-Larrea, L
    Costes, N
    Le Bars, D
    Broussolle, E
    MOVEMENT DISORDERS, 2002, 17 : S173 - S174
  • [49] A comparative preclinical PET imaging study between [11C]erlotinib and [18F]afatinib
    Slobbe, Paul
    Windhorst, Albert
    Stigter-van Walsum, Marijke
    Schuit, Robert
    Smit, Egbert
    Niessen, Heiko
    van Dongen, Guus
    Poot, Alex
    CANCER RESEARCH, 2014, 74 (19)
  • [50] β-amyloid Imaging Agents for PET - Preclinical Evaluation of [11C]PIB and [18F]Flutemetamol
    Pakkanen, A.
    Rokka, J.
    Wilson, I.
    Farrar, G.
    Solin, O.
    Rinne, J. O.
    Haaparanta, M.
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2009, 36 : S396 - S396